Research across Age-Related Macular Degeneration
Related studies from across the Age-Related Macular Degeneration family.
CFH Y402H and ARMS2 A69S polymorphisms are associated with increased risk of age-related macular degeneration
Specific genes linked to higher risk of age related macular degeneration
This meta-analysis evaluates the association between specific genetic polymorphisms and age-related macular degeneration (AMD) risk. The ana…
New research identifies two specific genetic variations that significantly increase the risk of developing age-related macular degeneration.
Aflibercept 8 mg at extended intervals yields comparable outcomes to 2 mg regardless of severity
Higher doses of aflibercept show similar results for macular degeneration
This post hoc descriptive subgroup analysis of a randomized controlled trial involving 869 treatment-naže patients with neovascular age-rela…
A higher dose of aflibercept may offer the same vision benefits as lower doses for patients with neovascular age-related macular degeneratio…
Migraine patients may have an increased risk of neovascular age-related macular degeneration
Migraine patients may face higher risk of certain eye conditions
This narrative review examines the association between migraine and various retinal conditions, including retinal migraine and AMD. The auth…
New research highlights a link between migraines and age-related macular degeneration, potentially impacting long-term vision for many suffe…
One-off 16 Gray stereotactic radiotherapy reduces anti-VEGF injections but results in worse visual acuity
Radiation for wet AMD cuts injections but harms vision
This randomized controlled trial of 411 patients with neovascular age-related macular degeneration found that one-off 16 Gray stereotactic r…
A single dose of radiation reduced the number of eye injections needed for wet AMD, but patients ended up with worse vision after four years…
Age, smoking, and systemic factors are associated with increased risk of age-related macular degeneration
Risk Factors Linked to Age-Related Macular Degeneration
This umbrella review synthesizes epidemiological evidence regarding 53 distinct risk factors for age-related macular degeneration. The analy…
New research identifies how lifestyle factors like smoking, diet, and high blood pressure may link to age-related macular degeneration.
Deep learning algorithms outperform ophthalmologists in detecting AMD and differentiating wet from dry cases
Deep learning algorithms outperform doctors in detecting age-related macular degeneration
This systematic review and meta-analysis evaluates the diagnostic performance of deep learning (DL) algorithms for identifying age-related m…
New data shows deep learning tools can identify eye diseases with higher accuracy than senior specialists, offering a powerful new way to sc…
FDA Approves Pavblu (aflibercept) for Neovascular AMD, RVO, DME, and DR
FDA approves Pavblu to treat several eye conditions that cause vision loss.
The FDA approved Pavblu (aflibercept) for neovascular AMD, macular edema following RVO, DME, and DR. It is a VEGF inhibitor administered by …
The FDA approved Pavblu (aflibercept) for wet age-related macular degeneration, macular edema, diabetic macular edema, and diabetic retinopa…
Obstructive Sleep Apnea Associated with Higher Odds of Age-Related Macular Degeneration
Large study links obstructive sleep apnea to higher risk of age-related macular degeneration
A systematic review and meta-analysis of 3,536,314 adults found that obstructive sleep apnea (OSA) was associated with higher odds of age-re…
A massive analysis of over 3.5 million people suggests obstructive sleep apnea is linked to a higher risk of age-related macular degeneratio…
Systematic review and meta-analysis shows aflibercept biosimilars match reference drug efficacy and safety in AMD and DME
Aflibercept biosimilars match the original drug for eye disease treatment
This systematic review and meta-analysis evaluated aflibercept biosimilars versus reference aflibercept for neovascular age-related macular …
A large review of 4064 patients found that aflibercept biosimilars work just as well as the original drug for two common eye conditions.
AI-based fluid volume quantification predicts visual acuity in neovascular AMD better than CST
AI fluid measurements better predict vision loss than thickness in AMD
This randomized phase III trial in 290 eyes with neovascular AMD found that AI-based quantification of intraretinal and subretinal fluid vol…
AI-based fluid volume tracking explains more vision changes than standard thickness measurements in macular degeneration patients.
Systematic review finds radiotherapy combined with anti-VEGF therapy increases risk of vision loss compared to anti-VEGF monotherapy in nAMD
Radiotherapy plus anti-VEGF therapy increases vision loss risk for nAMD
This systematic review and meta-analysis evaluated radiotherapy combined with anti-VEGF therapy versus anti-VEGF monotherapy for neovascular…
Adding radiotherapy to anti-VEGF treatment for wet macular degeneration was linked to a higher risk of vision loss compared to anti-VEGF alo…
Systematic review and meta-analysis finds no significant association between diabetic retinopathy and age-related macular degeneration
Diabetic retinopathy and age-related macular degeneration show no significant link
This systematic review and meta-analysis evaluates the association between diabetic retinopathy and age-related macular degeneration.
A meta-analysis found no significant relationship between diabetic retinopathy and age-related macular degeneration, though existing data ha…